BROWSE IAS 2009 COVERAGE
|
IAS 2009 Newsroom
- Upgrading Circumcision Tools to Prevent HIV (January 7, 2010)
An interview with Leslie Shelton
From TheBodyPRO.com
- Fighting HIV, One Grandmother at a Time (November/December 2009)
Necessity is the grandmother of invention in Khayelitsha.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Got Lube? (November/December 2009)
The slippery slope for African men who don't.
To read PDF, click here.
In Positively Aware, from Test Positive Aware Network
- Breaking Research From IAS 2009: A Discussion With HIV/AIDS Activists Bob Munk and Matt Sharp (August 26, 2009)
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBody.com
- Breaking Research on HIV/AIDS Treatment: An Interview With Joel Gallant, M.D., M.P.H. (August 5, 2009)
Tune in as Joel Gallant, M.D., M.P.H., one of the United States' foremost HIV experts, walks us through some of the most important findings in HIV treatment strategies presented at the conference.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- IAS Applauds South African Government for Commitment to Dramatically Scale Up HIV Treatment and Urges All Countries to Meet Their HIV/AIDS Commitments (July 31, 2009)
From International AIDS Society
- Vaginal Washing Increases HIV Infection Risk; Results for Dry Sex Less Clear-Cut (July 30, 2009)
A meta-analysis of data on vaginal practices and HIV infection from ten African cohorts has found that both vaginal washing with soap and wiping the vagina with cloths, tissues or paper were associated with an increased risk of acquiring HIV.
From aidsmap.com
- Everything Antiretroviral: 5th IAS Conference, Cape Town, South Africa (July 29, 2009)
A series of brief, down-to-earth summaries of studies on: the "when to start" question; pre-exposure prophylaxis; complications of HAART; aging and HIV; and the latest developments in the search for a cure.
To read PDF, click here.
In Project Inform Perspective, from Project Inform
- Nevirapine Matches Atazanavir/Ritonavir in 48-Week Study (July 29, 2009)
Nevirapine has equivalent efficacy to atazanavir/ritonavir when combined with tenofovir and emtricitabine in treatment-naive patients, results from the ARTEN study show.
From aidsmap.com
- Hepatitis B Vaccine Scale-Up and Treatment of HIV/HBV Coinfection Present Challenges (July 28, 2009)
Hepatitis B vaccine coverage has increased dramatically in recent years, but some regions still lag behind and collaboration with broader health programmes would aid scale-up, according to a symposium presentation on viral hepatitis.
From aidsmap.com
- Genotypic Test Matches Tropism Test in Predicting Who Benefits From CCR5 Inhibitors (July 28, 2009)
A genotypic test is just as accurate as a more expensive tropism test in determining which treatment-experienced patients are suitable for treatment with the CCR5 inhibitor maraviroc, researchers from the University of British Columbia reported.
From aidsmap.com
- Increased Risk of HIV Transmission in Serodiscordant Couples Wishing to Conceive (July 27, 2009)
Harm reduction interventions to avoid HIV transmission in heterosexual, serodiscordant couples who wish to have children are urgently needed, particularly in resource-poor settings, according to Sara Brubaker, M.D., M.P.H., of the University of California-San Francisco.
From aidsmap.com
- Raltegravir Moves Closer to Approval for First-Line Use in Europe (July 27, 2009)
A European regulatory committee has recommended expanding raltegravir's marketing authorization to include individuals initiating HAART. The recommendation comes days after trial data was presented about the safety and efficacy of the drug in treatment-naive patients.
From aidsmap.com
- Older Patients on Antiretroviral Therapy in West Africa Have Higher Risk of Death (July 27, 2009)
Patients over the age of 50 on antiretroviral treatment in West Africa are at increased risk for death compared to younger age groups, reported Didier Koumani Ekouevi.
From aidsmap.com
- Malaria Cases Fall With Each Year of HIV Treatment in Ugandan Patients (July 27, 2009)
Antiretroviral treatment was associated with a 75% decline in the incidence of malaria over four years in DART study participants, Ugandan and UK-based researchers reported.
From aidsmap.com
- Kesho Bora Study: Maternal Antiretroviral Therapy During Pregnancy and Breastfeeding Prevents More Infections Than Short-Course Prophylaxis (July 24, 2009)
Antiretroviral therapy for mothers that is initiated during pregnancy and continued throughout the breastfeeding period resulted in a significantly lower rate of mother-to-child HIV transmission when compared with the standard short-course regimen, investigators on the Kesho Bora study reported.
From aidsmap.com
- BAN Study: Giving Antiretroviral Therapy to Mothers or Antiretroviral Prophylaxis to Infants During Breastfeeding Equally Effective at Reducing HIV Transmission (July 24, 2009)
Either of two approaches -- maternal antiretroviral therapy or infant prophylaxis during the time of breastfeeding -- is equally safe and effective in reducing post-natal mother-to-child transmission of HIV, reports Charles Chasela of the University of North Carolina Project in Lilongwe, Malawi.
From aidsmap.com
- Nurse Management of Antiretroviral Therapy Matches Doctor Care in South African Trial (July 24, 2009)
Monitoring of antiretroviral treatment by nurses resulted in outcomes just as good as those seen when patients are monitored by doctors in South Africa, a large randomized trial has shown.
From aidsmap.com
- Low Bone Mineral Density in Botswana PrEP Trial Participants Raises Concerns (July 24, 2009)
Researchers conducting a trial of tenofovir and emtricitabine as pre-exposure prophylaxis (PrEP) in Botswana have found low bone mineral density levels in HIV-uninfected volunteers at enrollment.
From aidsmap.com
- DREAM Study: Extended Prenatal Antiretroviral Therapy Protects Against Mother-to-Child Transmission of HIV at Low and High CD4 Levels (July 24, 2009)
Antiretroviral therapy administered during pregnancy and breastfeeding reduces the risk of a woman transmitting HIV to her infant to just 2% by the time the child is six months of age -- even without a Cesarean section or formula feeding, according to a retrospective analysis of participants in the Drug Resource Enhancement Against AIDS and Malnutrition (DREAM) program in sub-Saharan Africa.
From aidsmap.com
- Mma Bana Study: Mother-to-Child Transmission Reduced Below 1% in Breastfeeding Mothers Who Receive ART (July 24, 2009)
Antiretroviral therapy during pregnancy and breastfeeding resulted in a mother-to-child transmission rate of less than 1% in a large randomized comparison of two triple-drug combinations in women with CD4 counts above 200 cells/mm3, according to data from the Mma Bana study.
From aidsmap.com
- Africa: Where to Find a Million New Nurses? (July 24, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- IAS Conference: Low-Cost CD4 Tests; HIV Prevalence Among Pregnant Zimbabweans; Treating HIV-TB With ARVs; Vaccine Trials (July 24, 2009)
A brief recap of selected mainstream media coverage of research presented at IAS 2009.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Treating HIV Earlier Could Save 76,000 Lives in South Africa (July 23, 2009)
A new study finds that initiating antiretroviral therapy when a patient's CD4+ cell count drops below 350 cells/mm3 could save 76,000 lives in South Africa alone over the next five years.
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Anal Cancer in Men With HIV Much More Common in Post-HAART Era: Could HPV Vaccination Help? (July 23, 2009)
The annual incidence of anal cancer among people with HIV has continued to increase in recent years and now stands at 128 cases per 100,000, said Nancy Crum-Cianflone of the U.S. Infectious Disease Clinical Research Program. This is nearly 100 times the rate in the general population.
From aidsmap.com
- Sustained Response to Interferon Improves Fibrosis in HIV/HCV-Coinfected Patients (July 23, 2009)
HIV-infected people who achieve a sustained virological response to hepatitis C treatment using pegylated interferon plus ribavirin may experience regression of fibrosis and even cirrhosis, according to study findings.
From aidsmap.com
- Early Tests of Maraviroc as Microbicide Produce Less Activity Than Expected (July 23, 2009)
Preclinical ex-vivo tests of the entry inhibitor drug maraviroc as a possible microbicide have found that the drug only produced a moderate protective effect against HIV: a 50% to 60% inhibition of HIV infection of penile tissue and an 85% inhibition in colorectal tissue, when given at high doses.
From aidsmap.com
- Acyclovir Reduces Disease Progression and Death in People With HIV by Nearly 20% -- But Doesn't Reduce Transmission Risk (July 23, 2009)
HIV-infected people given 400 mg of acyclovir twice-daily as part of a trial to see if the drug reduced HIV transmission in serodiscordant couples were 17% less likely to progress to AIDS, have to start antiretroviral therapy, or die.
From aidsmap.com
- Boosted and Unboosted Atazanavir Maintain Viral Suppression Equally Well (July 23, 2009)
Unboosted atazanavir taken once-daily as part of a combination antiretroviral regimen can keep viral load undetectable in patients who discontinue ritonavir, researchers reported.
From aidsmap.com
- Boosted Darunavir Monotherapy Works Well in Two Studies (July 23, 2009)
Ritonavir-boosted darunavir alone maintains HIV suppression in most patients who achieved an undetectable viral load on combination antiretroviral therapy, according to two studies.
From aidsmap.com
- Delays in Starting Treatment Common in ART Programs (July 23, 2009)
Late initiation of antiretroviral treatment following diagnosis is contributing to the continuing high death rate among people who present with low CD4+ cell counts in eight sub-Saharan African countries.
From aidsmap.com
- Antiretrovirals and Condoms Will Have More Effect on HIV in South Africa Than Circumcision, Model Finds (July 23, 2009)
In preliminary results from a mathematical model set up by researchers from the British Columbia Centre for Excellence in HIV/AIDS, male circumcision was found to have a considerably lower impact than condom use or antiretroviral therapy coverage on new HIV infection rates and on death rates in men in South Africa.
From aidsmap.com
- ART for Mothers Leading to Decline in Child Deaths, KwaZulu Natal Study Finds (July 23, 2009)
A major decrease in the childhood mortality rate in children under the age of two, observed between 2001 and 2006 in northern rural KwaZulu Natal, South Africa, was associated with the rollout of antiretroviral therapy in that region.
From aidsmap.com
- Study Examines Efficacy of Isentress (Raltegravir) (July 23, 2009)
Isentress failed to "reduce low-level reservoirs of HIV," in a 53-participant study of HIV-positive patients whose viral loads were already at undetectable levels.
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- IPS Examines How Funding Cuts Might Affect HIV/AIDS Treatment Programs Worldwide (July 23, 2009)
"Failure to sustain funding for HIV/AIDS treatment programmes could lead to a rising number of deaths, particularly in Africa," Inter Press Service reports.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Antiretroviral Roll-Out Results in Major TB Decline in South African Study (July 22, 2009)
The roll-out of antiretroviral treatment to cover 90% of eligible people has resulted in a significant decline in new cases of tuberculosis (TB) in a South African township, demonstrating for the first time the potential of antiretroviral treatment to make major inroads into the burden of TB in high prevalence countries.
From aidsmap.com
- At Conclusion of Major International Scientific Meeting on AIDS, Researchers Highlight Evidence of Important Benefits From HIV Investments for Other Health Conditions, Including Those Affecting Women and Children (July 22, 2009)
Scientists urge support for additional investments to strengthen health systems, using recent AIDS investments as a model.
To read PDF, click here.
From International AIDS Society
- Genetic Test Predicts Response to Maraviroc in Treatment-Experienced HIV Patients (July 22, 2009)
To read PDF, click here.
From British Columbia Centre for Excellence in HIV/AIDS
- New Research From IAS 2009 (July 22, 2009)
To read PDF, click here.
From International AIDS Society
- For Women, Circumcised Partner May Be Better Lover (July 22, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Cost of ART Delivery in Malawi Possible Within WHO-Recommended Health Budget (July 22, 2009)
Total additional costs for sustaining universal antiretroviral therapy (ART) access in a high-prevalence, extremely poor rural area of Malawi are well within budget guidelines set by the World Health Organization for a minimal basic health package, reported Mary Bemelmans.
From aidsmap.com
- Lopinavir/Ritonavir Found to Be a Cost-Effective First-Line Treatment After Single-Dose Nevirapine in South Africa (July 22, 2009)
First-line lopinivar/ritonavir is more cost-effective than first-line nevirapine in women previously exposed to single-dose nevirapine, reported Andrea Ciaranello.
From aidsmap.com
- HIV Infection Not Found to Be Associated With Drug-Resistant TB in Khayelitsha, South Africa (July 22, 2009)
An extremely high prevalence of rifampicin-resistant tuberculosis (TB) -- 72 cases per 100,000 people per year -- has been found in a cross-sectional study of individuals with suspected TB conducted in Khayelitsha township, situated 40 km outside of Cape Town.
From aidsmap.com
- Small Clinical Trial Examines Drug's Ability to Reduce HIV in Body (July 22, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Research Finds Resurgence of TB, Diarrhea and Malnutrition in Zimbabwe Due to Hyperinflation and Economic Collapse (July 22, 2009)
The economic crisis since 2000 in Zimbabwe has led to a rapid rise in tuberculosis (TB) cases and rising rates of malnutrition, reported Michael Silverman, M.D. However, he also noted that it appears HIV prevalence in pregnant women is decreasing in the country.
From aidsmap.com
- Once-Daily Kaletra Found as Safe and Effective as Twice-Daily Dosing in Treatment-Experienced Patients (July 22, 2009)
Lopinavir/ritonavir taken once-daily as part of a combination antiretroviral regimen worked as well as the approved twice-daily dose in previously treated patients -- but also led to better adherence, researchers reported.
From aidsmap.com
- Experimental Integrase Inhibitor GSK-572 Looks Good in Early Studies (July 22, 2009)
A second-generation integrase inhibitor -- S/GSK1349572, or GSK-572 for short -- demonstrated very good antiviral activity in a 10-day monotherapy study, researchers reported.
From aidsmap.com
- High-Risk HPV Infection Raises HIV Risk at Least Fourfold; HPV Vaccine Study Suggested (July 22, 2009)
Infection with one or more of the cancer-causing subtypes of human papillomavirus (HPV) multiplied the risk of acquiring HIV among young men by 4.5-fold in a randomized controlled study of circumcision in South Africa.
From aidsmap.com
- "Test and Treat" Unlikely to Halt Washington, D.C., HIV Epidemic, Study Suggests (July 22, 2009)
A mathematical model from the Harvard School of Public Health, based on the population of Washington, D.C., has found that recalling every adult for annual HIV screening and treating every HIV-positive person with antiretrovirals as soon as they were diagnosed would only result in a 30% decline in the proportion of the HIV-positive population who had non-suppressed viral loads.
From aidsmap.com
- Improved Surveillance of Cervical Cancer Recommended in Populations With High HIV Prevalence (July 22, 2009)
Cervical cancer prevention guidelines may need to be reviewed to address the particular needs of HIV-infected women, due to poorer outcomes of treatment for precancerous cervical changes, data from a South African study suggest.
From aidsmap.com
- Prevention, Vaccines Addressed at IAS Conference (July 22, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Longer, Stronger HIV Drug Regimen for Breastfeeding Women Cuts Mother-to-Child Transmission Rate, Study Finds (July 22, 2009)
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- Biomedical HIV Prevention, Including Microbicides, Vaccines, Circumcision and PrEP (July 21, 2009)
The lesson we have to learn from the trials that have been completed is that we need to do much more fundamental research, on immunologic mechanisms to further development of vaccines and potentially of microbicides.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Immune Control of HIV Replication (July 21, 2009)
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- "Treatment as Prevention" Must Not Violate Human Rights, Conference Told (July 21, 2009)
The expansion of HIV testing programs and the advocacy of universal testing and treatment of those who test positive as a means of prevention must not violate the human rights of target populations, said representatives from Human Rights Watch and the AIDS and Rights Alliance of Southern Africa.
From aidsmap.com
- U.S. Officials Outline Obama Administration's AIDS Policy (July 21, 2009)
The U.S. government will continue to fund HIV/AIDS research, prevention and treatment efforts as part of a more comprehensive global health strategy, U.S. officials said at IAS 2009.
From aidsmap.com
- Two New Analyses Add to Abacavir Cardiovascular Risk Debate (July 21, 2009)
Two studies presented at IAS 2009 found no association between abacavir and increased risk of heart attack or stroke, and underlined the importance of confounding risk factors.
From aidsmap.com
- DART Study Shows HIV Treatment Without Lab Monitoring Safe, Effective in Africa (July 21, 2009)
Antiretroviral treatment can be delivered safely without laboratory monitoring in sub-Saharan Africa, say the investigators of the DART study.
From aidsmap.com
- New Measures of Cardiovascular Dysfunction in People With HIV Pose New Questions (July 21, 2009)
Two studies have generated differing results regarding the use of new methods to detect changes in arteries that could give rise to cardiovascular disease.
From aidsmap.com
- Africa Stands at a Threshold in HIV Response (July 21, 2009)
Focus on the epicenter of the HIV epidemic in South Africa highlights both significant increases in access to treatment and the millions still in need.
To read PDF, click here.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from International AIDS Society
- HIV's Silent Dangers Make Early HIV Treatment Critical, Expert Says (July 21, 2009)
A discussion about inflammation, early treatment and universal treatment access -- Wafaa El-Sadr, M.D., M.P.H., United States.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Africa HIV City Care Questioned (July 21, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Advocates for Health Millennium Development Goals Unite to Demand World Leaders Honor Funding Commitments (July 21, 2009)
Found: hundreds of billions of dollars to save the wealthiest corporations; lost: billions of dollars of G8 commitments to save millions of human lives.
To read PDF, click here.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from Center for Health and Gender Equity
- Global AIDS Coordinator Addresses Obama's Global HIV/AIDS Policy Agenda (July 21, 2009)
"Each government ultimately holds responsibility for the health of its citizens," and U.S. policies in the Obama era would seek to support country programs and encourage more national government buy-in and leadership, said U.S. Global AIDS Coordinator Eric Goosby at IAS 2009. "The end goal is for each country to control its responses both strategically and, eventually, financially," he said.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Antiretrovirals Can Be Used to Prevent Spread of HIV/AIDS, Model Shows (July 21, 2009)
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- A Review of Six Years of Statewide Testing for Acute HIV in North Carolina (July 20, 2009)
An interview with JoAnn Kuruc, M.S.N., R.N.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Female Patients' Stigma, Disclosure Concerns Reduce Their Access to HIV and TB Care in Africa, Study Shows (July 20, 2009)
The lower social status of Ugandan women compared to men is largely to blame for their difficulty in accessing HIV or tuberculosis (TB) care, according to David Kaawa-Mafigiri, Ph.D., M.P.H.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- The Future of U.S. and Global HIV Research, Policy and Program Implementation (July 20, 2009)
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- African Americans, Women Have Lower Virologic Response Rates in Both Arms of Head-to-Head Antiretroviral Trial (July 20, 2009)
Race and gender may prove to be a more critical factor than we think in virologic response to HIV medications. In the large HEAT study, which compared two first-line HAART regimens, Kimberly Smith, M.D., M.P.H., et al found that in both study arms, fewer African Americans (versus white patients) and females (versus males) achieved a viral load of less than 50 copies/mL.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Improving Response to HIV Goes Hand-in-Hand With Improving Overall Health Systems, Experts Say (July 20, 2009)
The battle against HIV is not in competition with battles against other major diseases in the developing world, prominent researchers and experts asserted at IAS 2009. Quite the opposite: The lessons learned during the global response to HIV have led to improvements and innovations in health systems that can yield huge benefits in fighting many of the world's worst pandemics, argue Jacqueline Bataringaya, M.D., Wafaa El-Sadr, M.D., M.P.H., Michel Kazatchkine, M.D., and Alan Whiteside, Ph.D.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Opening Session Remarks by Dr. Julio Montaner, President, International AIDS Society and IAS 2009 International Chair (July 20, 2009)
Since the IAS 2000 conference in Durban, South Africa, "we have seen dramatic progress in access to treatment, care and prevention in resource-limited countries," Montaner said. However, "Despite such progress, we must not be complacent. Major concerns remain."
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Prevention of Mother-to-Child Transmission (July 20, 2009)
Study Summary by Louise Kuhn, Ph.D.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- If We Can't Overcome HIV Stigma and Discrimination, Access to Care Won't Improve in Africa, Advocate Says (July 20, 2009)
"Right now, we're standing in a sinkhole, with regards to HIV and TB [tuberculosis] treatment" in Africa, said HIV/AIDS advocate Paula Akugizibwe in an eloquent, passionate speech at IAS 2009. "Until we do some serious work, and invest money and time on creating human rights sensitization ... and the imperative of governments to fund this right, then everything else we're doing is essentially self-defeating."
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- HIV Treatment as Prevention: How Many Lives Could Be Saved? (July 20, 2009)
If every person in sub-Saharan Africa received voluntary, annual HIV testing and started antiretroviral therapy immediately after diagnosis, HIV incidence would drop 95% in 10 years and more than seven million deaths would be averted, according to a theoretical model presented by Reuben Granich, M.D., M.P.H.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- AIDS Vaccine Funding Down 10% in 2008 (July 20, 2009)
Funding for AIDS vaccine research fell by 10% in 2008, the first decline in a decade, according to figures released by the HIV Vaccine and Microbicide Resource Tracking Working Group.
From aidsmap.com
- AIDS Exceptionalism a Defensible Concept, Says Stephen Lewis (July 20, 2009)
The idea that AIDS is an exceptional disease requiring an exceptional response is a perfectly defensible concept, Stephen Lewis, the former United Nations Special Envoy on AIDS in Africa, told the opening session of IAS 2009.
From aidsmap.com
- Risk Factors for Treatment Failure in Children: Ritonavir and Advanced Disease Strong Predictors (July 20, 2009)
Ritonavir used alone as a third drug is a strong predictor of virologic failure in children receiving antiretroviral treatment, according to an analysis of data from the International Epidemiological Databases to Evaluate AIDS (leDEA) Southern Africa pediatric antiretroviral cohorts, presented by Mary Ann Davies.
From aidsmap.com
- Nevirapine-Based Treatment Regimen for Children Exposed to Single-Dose Nevirapine Shown to Be Effective (July 20, 2009)
Switching to nevirapine-based antiretroviral therapy as a treatment strategy for HIV-infected children previously exposed to single-dose nevirapine has the potential to maintain viral suppression in children, according to the data of the NEVEREST study presented by Dr. Ashraf Coovadia.
From aidsmap.com
- Health Systems Are Benefiting From AIDS Spending, Experts Say (July 20, 2009)
The belief that global health initiatives such as PEPFAR and the Global Fund are not strengthening health systems is a myth, Global Fund executive director Michel Kazatchkine told reporters.
From aidsmap.com
- Innovative, Cost-Effective and Patient-Friendly Methods for Delivery of HIV Care Feasible in Resource-Limited Settings (July 20, 2009)
Innovative methods of delivery of HIV care using home based care and nurse initiated antiretroviral treatment are feasible and can have good treatment outcomes in resource-limited settings such as Uganda and Lesotho, delegates heard on Monday at the 5th International AIDS Society Conference in Cape Town.
From aidsmap.com
- Large-Scale Pediatric Treatment Shows Success in Southeast Asia (July 20, 2009)
Long-term treatment success in children in both Thailand and Cambodia demonstrates the sustainability of pediatric antiretroviral therapy in resource-limited settings at clinic, district and provincial levels as reported in studies by Michelle McConnell and Petros Isaakidis, respectively.
From aidsmap.com
- Getting People Onto Treatment, Not Earlier Treatment, Must Be Priority, Conference Warned (July 20, 2009)
Debates about whether to start treatment at a CD4 count of 350 in developing countries ignore the fact that current programs are doing very badly at retaining patients in care after diagnosis or starting people on treatment before they become seriously ill, said Dr. Francois Venter, President of the South African HIV Clinicians.
From aidsmap.com
- AIDS Drugs Shortage Threatens Africa (July 20, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- Nevirapine Sports Better Lipid Profile Than Atazanavir, Study Suggests (July 20, 2009)
Patients taking nevirapine may have a lower risk of developing cardiovascular disease than those taking ritonavir-boosted atazanavir, according to a 569-patient study by European researchers. The study found that although nevirapine's efficacy was non-inferior to that of atazanavir, nevirapine appeared to have a more favorable lipid profile.
In Kaiser Daily U.S. HIV/AIDS Report, from Henry J. Kaiser Family Foundation
- IAS Conference Begins, Report Says Economic Crisis Forcing Africans Living With HIV/AIDS Off Life-Saving Medications (July 20, 2009)
Medecins Sans Frontieres said that a shortage of antiretrovirals in six African nations would cost the lives of thousands and reverse a decade of gains in HIV/AIDS treatment and prevention. Meanwhile, Julio Montaner, president of the International AIDS Society, excoriated leaders of the world's richest nations as IAS 2009 opened. "The silence of the G8 leaders [on HIV/AIDS] is not just pathetic, it is criminal," he said.
In Kaiser Daily Global Health Policy Report, from Henry J. Kaiser Family Foundation
- Benefit of HIV Treatment as Prevention Underscores Need to Avert Treatment Disruptions and Expand Access to Reach Universal Targets (July 20, 2009)
Researchers speaking in the first plenary session of IAS 2009 offered insights into current and future HIV prevention research and examined genetics and HIV-related inflammation as avenues for new treatments.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from International AIDS Society
- Can the Establishment and Persistence of HIV Reservoirs Ever Be Controlled? (July 19, 2009)
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- Speech by Stephen Lewis at the International AIDS Society Conference (July 19, 2009)
From Stephen Lewis Foundation
- "We're Not Doing Enough," Say Global Leaders on HIV as IAS 2009 Opens (July 19, 2009)
In a wide-ranging, impassioned press conference at the opening of IAS 2009, Hoosen Coovadia, M.D., Vuyiseka Dubula, Stephen Lewis and Julio Montaner, M.D., discuss some of the overarching themes and priorities of this year's conference, many of which focus on a desperate need to renew attention (and funding) to the precarious state of efforts to prevent and treat HIV in resource-poor countries.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from TheBodyPRO.com
- G8 Leaders Must Keep Their AIDS Promises, IAS Conference Told (July 19, 2009)
G8 leaders must meet their commitments to finance universal access to treatment and prevention despite the economic crisis, activists and scientists told the opening session of IAS 2009.
From aidsmap.com
- Scientists Warn Against Retrenchment on AIDS (July 19, 2009)
Amidst a lingering global recession and indications that world leaders are retreating on previous commitments to universal access to HIV prevention and treatment, researchers, implementers and community leaders at IAS 2009 warned of dire public health consequences resulting from a retrenchment on the global fight against AIDS.
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from International AIDS Society
- WHO to Consult People With HIV on Treatment Guidelines (July 18, 2009)
People living with HIV are to be consulted on the development of new World Health Organization treatment guidelines for low- and middle-income settings, due to be released in November 2009.
From aidsmap.com
- Small Loans Change Lives of Togolese HIV/AIDS Victims (July 9, 2009)
In CDC HIV/Hepatitis/STD/TB Prevention News Update, from U.S. Centers for Disease Control and Prevention
- The Treatment Timebomb (PDF) (July 2009)
"We can predict many of the changing treatment needs of people living with HIV in the coming decade and they are not compatible with treatments and prices available today," warns this report created for the United Kingdom Parliament. "Maintaining HIV treatment to keep people alive will cripple developing economies, or place unbearable strains on richer countries trying to support them. Action is needed now, to avert crisis later."
In The 5th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention, from The All Party Parliamentary Group on AIDS
|
Advertisement
|
Email
Glossary